Exponential Enhancement of Oncolytic Vesicular Stomatitis Virus Potency by Vector-mediated Suppression of Inflammatory Responses In Vivo
Open Access
- 1 January 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (1) , 146-153
- https://doi.org/10.1038/sj.mt.6300343
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA100830)
- Bundesministerium für Bildung und Forschung (01GU0505)
- Deutsche Krebshilfe
This publication has 45 references indexed in Scilit:
- Regulation of ligands for the activating receptor NKG2DImmunology, 2007
- Prophylactic Alpha Interferon Treatment Increases the Therapeutic Index of Oncolytic Vesicular Stomatitis Virus Virotherapy for Advanced Hepatocellular Carcinoma in Immune-Competent RatsJournal of Virology, 2005
- Review article: the changing epidemiology of hepatocellular carcinoma in CanadaAlimentary Pharmacology & Therapeutics, 2005
- Oncolytic HSV Exerts Direct Antiangiogenic Activity in Ovarian CarcinomaHuman Gene Therapy, 2005
- Eradication of advanced hepatocellular carcinoma in rats via repeated hepatic arterial infusions of recombinant VSVHepatology, 2004
- Syncytia Induction Enhances the Oncolytic Potential of Vesicular Stomatitis Virus in Virotherapy for CancerCancer Research, 2004
- Altered expression of antiviral cytokine mRNAs associated with cyclophosphamide's enhancement of viral oncolysisGene Therapy, 2004
- Viral evasion of natural killer cellsNature Immunology, 2002
- Natural killer (NK) cells prevent virus production in cell cultureBone Marrow Transplantation, 1999
- NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate CytokinesAnnual Review of Immunology, 1999